Rebecca Robbins
Posts
Kroger Agrees to Pay $1.2 Billion to Settle Opioid Claims
The grocery chain, which did not admit wrongdoing, is the latest company accused of helping to fuel the opioid crisis to announce a settlement.
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion
Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.
Merck Sues Over Medicare Drug-Price Negotiation Law
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea...
F.D.A. Approves Drug for Rare Form of A.L.S.
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.
A Drug Company Exploited a Safety Requirement to Make Money
With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.